In the wake of a devastating inquest, the family of Oliver Robinson, who took his own life in November 2023, is advocating for stringent regulations surrounding private cannabis clinics in the UK. The inquest revealed that Robinson’s prescription for medicinal cannabis likely contributed to his death and impeded his access to appropriate mental health care. As a result, calls for reform are growing, highlighting potential risks for vulnerable patients seeking alternative treatments.
A Troubling Prescription History
Oliver Robinson, 34, struggled with mental health issues for several years, undergoing treatment for depression and addiction at the Priory, a private mental health facility, from 2019 to 2022. After feeling that conventional therapies had failed him, Robinson sought relief through medicinal cannabis, prescribed by Curaleaf Clinic in May 2022. However, his family believes that this decision ultimately exacerbated his condition rather than alleviating it.
In January 2024, the coroner’s inquest determined that Robinson’s cannabis prescription had “probably contributed to his death” and acted as a barrier to receiving effective psychiatric care. This landmark ruling has raised critical questions about the standards of care provided by private cannabis clinics, particularly for those with serious mental health issues.
Growing Concerns Over the Industry
The landscape of medicinal cannabis in the UK changed in 2018 when the government legalised cannabis-based medicinal products (CBMPs) following a high-profile case involving a child with severe epilepsy. Since then, although the NHS has prescribed only a limited number of licensed CBMPs, the private sector has seen a dramatic increase in unlicensed cannabis prescriptions. Data indicates that in 2024, over 659,000 unlicensed cannabis products were prescribed privately, a significant rise from the previous year.
Concerns about the safety of these unlicensed treatments have been echoed by experts. Dr Pavan Chahl, a psychiatrist, noted during the inquest that existing guidelines discourage the prescription of medicinal cannabis to individuals with a history of severe psychiatric disorders, citing insufficient evidence for its efficacy in treating depression and the potential for it to worsen such conditions.
A Family’s Fight for Change
In light of their tragic loss, Oliver’s brother, Alexander Robinson, is spearheading a campaign for reform, dubbed “Oliver’s Law.” This initiative seeks to impose stricter regulations on private cannabis clinics, which could include an outright ban on prescribing cannabis to patients with serious mental health conditions, mandatory consultations with NHS mental health teams, and face-to-face assessments for complex cases.
Alexander’s concerns stem from a belief that the current safeguards are inadequate to protect vulnerable patients. He emphasised the need for greater oversight and accountability within the rapidly expanding cannabis sector, particularly as more individuals turn to these treatments in desperation. “If things do not change, he is not going to be the last,” he warned, highlighting the urgency of the situation.
Failures in Care and Accountability
The inquest into Oliver’s death uncovered a series of failures in his care, including reliance on outdated medical records and a lack of communication between Curaleaf and other healthcare providers involved in his treatment. The coroner’s report identified that the prescribing decisions were made without a comprehensive understanding of Oliver’s complex mental health history, which ultimately contributed to his tragic fate.
In response to the inquest findings, Curaleaf expressed condolences to Robinson’s family and stated its commitment to responsible clinical governance. The clinic asserted that its prescribing practices are informed by a multidisciplinary team and a commitment to continuous improvement. However, the Care Quality Commission (CQC), which oversees these clinics, has indicated that it will review the coroner’s report to determine if regulatory action is warranted.
Why it Matters
The case of Oliver Robinson underscores the critical need for rigorous oversight and regulation of private cannabis clinics in the UK. As the demand for alternative treatments grows, ensuring that vulnerable patients receive safe and effective care is paramount. The tragic outcome of Robinson’s story serves as a stark reminder of the potential hazards associated with unregulated medical practices and highlights a pressing need for reforms that protect those grappling with mental health challenges. The call for “Oliver’s Law” is not just a plea for change; it is a rallying cry for the safety and dignity of patients who deserve to receive care that is both effective and humane.
